Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Gene therapy: a pharmacokinetic/pharmacodynamic modelling overview.

Parra-Guillén ZP, González-Aseguinolaza G, Berraondo P, Trocóniz IF.

Pharm Res. 2010 Aug;27(8):1487-97. doi: 10.1007/s11095-010-0136-4. Epub 2010 Apr 13. Review.

PMID:
20387096
2.

Vectors and strategies for nonviral cancer gene therapy.

Pahle J, Walther W.

Expert Opin Biol Ther. 2016;16(4):443-61. doi: 10.1517/14712598.2016.1134480. Epub 2016 Jan 13. Review.

PMID:
26761200
3.

Intracellular trafficking of nonviral vectors.

Medina-Kauwe LK, Xie J, Hamm-Alvarez S.

Gene Ther. 2005 Dec;12(24):1734-51. Review.

PMID:
16079885
4.

In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.

Audouy SA, de Leij LF, Hoekstra D, Molema G.

Pharm Res. 2002 Nov;19(11):1599-605. Review.

PMID:
12458664
5.

Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.

Mazda O.

Curr Gene Ther. 2002 Sep;2(3):379-92. Review.

PMID:
12189722
6.

Principles of safety, efficacy and stability in gene therapy--review.

Hu CS, Hong JY, Douglas WL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Jun;12(3):392-6. Review.

PMID:
15228676
7.

Nonviral DNA vectors for immunization and therapy: design and methods for their obtention.

Rodríguez EG.

J Mol Med (Berl). 2004 Aug;82(8):500-9. Epub 2004 Jun 3. Review.

PMID:
15175860
8.

High-capacity adenoviral vectors for gene transfer and somatic gene therapy.

Kochanek S.

Hum Gene Ther. 1999 Oct 10;10(15):2451-9. Review.

PMID:
10543611
9.

Nonviral vectors in the new millennium: delivery barriers in gene transfer.

Nishikawa M, Huang L.

Hum Gene Ther. 2001 May 20;12(8):861-70. Review.

PMID:
11387052
10.

Biosafety of recombinant adeno-associated virus vectors.

Dismuke DJ, Tenenbaum L, Samulski RJ.

Curr Gene Ther. 2013 Dec;13(6):434-52. Review.

PMID:
24195602
11.

Lipid nanoparticles for gene delivery.

Zhao Y, Huang L.

Adv Genet. 2014;88:13-36. doi: 10.1016/B978-0-12-800148-6.00002-X. Review.

12.

Nonviral ocular gene therapy: assessment and future directions.

Conley SM, Cai X, Naash MI.

Curr Opin Mol Ther. 2008 Oct;10(5):456-63. Review.

13.

Efficacy of nonviral gene transfer in the canine brain.

Oh S, Pluhar GE, McNeil EA, Kroeger KM, Liu C, Castro MG, Lowenstein PR, Freese A, Ohlfest JR.

J Neurosurg. 2007 Jul;107(1):136-44.

14.

Gene transfer vectors targeted to human prostate cancer: do we need better preclinical testing systems?

Maitland N, Chambers K, Georgopoulos L, Simpson-Holley M, Leadley R, Evans H, Essand M, Danielsson A, van Weerden W, de Ridder C, Kraaij R, Bangma CH; GIANT FP6 Consortium.

Hum Gene Ther. 2010 Jul;21(7):815-27. doi: 10.1089/hum.2009.210. Review.

PMID:
20030557
15.

Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector.

Takahashi Y, Nishikawa M, Takakura Y.

Front Biosci (Schol Ed). 2012 Jan 1;4:133-41. Review.

PMID:
22202048
16.

Recent advances in characterization of nonviral vectors for delivery of nucleic acids: impact on their biological performance.

Oliveira C, Silveira I, Veiga F, Ribeiro AJ.

Expert Opin Drug Deliv. 2015 Jan;12(1):27-39. doi: 10.1517/17425247.2014.945421. Epub 2014 Aug 21. Review.

PMID:
25141765
17.

Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies.

Ohlfest JR, Freese AB, Largaespada DA.

Curr Gene Ther. 2005 Dec;5(6):629-41. Review.

PMID:
16457652
18.

More trouble ahead; is gene therapy coming of age?

Tan PH, Janes SE, Handa AI, Friend PJ.

Expert Opin Biol Ther. 2008 May;8(5):561-7. doi: 10.1517/14712598.8.5.561 .

PMID:
18407761
19.

[Advances in cationic polymers used as nonviral vectors for gene delivery].

Ren X, Yang L, Liang X, Liu Z, Deng Y.

Sheng Wu Gong Cheng Xue Bao. 2013 May;29(5):568-77. Review. Chinese.

PMID:
24010355
20.

Improvements in gene therapy: averting the immune response to adenoviral vectors.

Ritter T, Lehmann M, Volk HD.

BioDrugs. 2002;16(1):3-10. Review.

PMID:
11908997

Supplemental Content

Support Center